Efficacy analysis of Dahuang Fuzi Decotion on treating severe acute pancreatitis in patients with ARDS

吕春雨,路小光,战丽彬,康新,于健,范治伟,杨荣利,王小周,梁正凯
DOI: https://doi.org/10.3760/cma.j.issn.1671-0282.2013.04.014
2013-01-01
Abstract:Objective To observe the therapeutic efficacy of Dahuang Fuzi Decoction (a Chinese herbal medicine preparation with Rheum officinale Baill and Aconitum carmichaeli Debx) in patients with acute respiratory distress syndrome (ARDS) and severe acute pancreatitis (SAP).Methods A prospective,multi-center,randomized controlled clinical trials were carried out in 60 patients with ARDS and SAP in three tertiary university teaching hospitals in Dalian from July 2011 to August 2012.These patients were divided into Dahuang Fuzi Decoction treatment group (n =20),Dahuang Decoction treatment group (n =20) and Control group (n =20).All patients of 3 groups were treated with comprehensive measures including intensive care,fasting,continuous gastrointestinal decompression,mechanical ventilation,sedative antispasmodics,suppression of pancreatic exocrine,nutritional support,and antiinfection measures.In patients of control group,retention enema with 200 ml warm soap water for 30 min twice a day.In addition to retention enema as given to patients of control group,the patients of Dahuang Fuzi Decotion group and Dahuang Decotion group were treated with Dahuang Fuzi Decoction and Dahuang Decoction respectively.The APACHE Ⅱ scores and mortalities in 3 groups of patients were observed before treatment and after treatment for 7 days.At the same time,the liver and renal functions,blood amylase,blood calcium,endotoxin,routine blood examination,C-reactive protein (CRP),TNF-α,IL-1,blood gas analysis were detected before and after treatment for 1 d,3 d and 7 days.Results Compared with the control group and Dahuang Decoction group,the blood amylase,blood calcium,PaO2 and PaO2/ FiO2,endotoxin,APACHE-Ⅱ score,and mortality in Dahuang Fuzi Decoction group were markedly improved after treatment for3d and7 days (P < 0.05 or P < 0.01),whereas the levels of WBC.ALT.BUN.Cr.CRP.TNF-α.And IL-1 in blood samples were more or less improved in certain extent (P < 0.05).There was more improvement in above biomarkers found in Dahuang Fuzi Decotion treatment group than that in Dahuang Decoction treatment group (P < 0.05).Conclusions Dahuang Fuzi Decoction showed therapeutic effects on SAP-ARDS patients evidenced by reduction in inflammatory mediators,improved oxygenation function,lowering mortality,and significantly improved the prognosis of SAP-ARDS patients,and the therapeutic effect of Dahuang Fuzi Decotion is significantly superior over that of Dahuang Decotion.
What problem does this paper attempt to address?